(Q45934007)

18 December 2017

title

Antiproteinuric effect of angiotensin-converting enzyme inhibitors and an angiotensin II receptor blocker in patients with lupus nephritis. (English)

1 reference

18 December 2017

author name string

N Kitamura

1

1 reference

18 December 2017

Y Matsukawa

2

1 reference

18 December 2017

M Takei

3

1 reference

18 December 2017

S Sawada

4

1 reference

18 December 2017

publication date

1 May 2009

1 reference

18 December 2017

Journal of International Medical Research

published in

1 reference

18 December 2017

volume

37

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

892-898

1 reference

18 December 2017

Inhibition of the renin-angiotensin system and chronic kidney disease

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Renoprotective effect of the addition of losartan to ongoing treatment with an angiotensin converting enzyme inhibitor in type-2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Prognostic factors in lupus nephritis. Contribution of renal histologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension--a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000903700335

10.1177/147323000903700335

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017